Larvicidal activity of Copaifera sp. (Leguminosae) oleoresin microcapsules against Aedes aegypti (Diptera: Culicidae) larvae

Parasitology Research - Tập 110 - Trang 1173-1178 - 2011
Luiz Alberto Kanis1, Josiane Somariva Prophiro2, Edna da Silva Vieira1, Mariane Pires do Nascimento1, Karine Modolon Zepon1, Irene Clemes Kulkamp-Guerreiro3, Onilda Santos da Silva4
1Grupo de Pesquisa em Tecnologia Farmacêutica—TECFARMA, Universidade do Sul de Santa Catarina, Tubarão, Brazil
2Grupo de Pesquisa em Imunoparasitologia—IMPAR, Universidade do Sul de Santa Catarina, Tubarão, Brazil
3Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
4ICBS, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

Tóm tắt

Studies have demonstrated the potential of Copaifera sp. oleoresin to control Aedes aegypti proliferation. However, the low water solubility is a factor that limits its applicability. Thus, the micro- or nanoencapsulation could be an alternative to allow its use in larval breeding places. The purpose of this study was to evaluate if achievable lethal concentrations could be obtained from Copaifera sp. oleoresin incorporated into polymers (synthetic or natural) and, mainly, if it can be sustained in the residual activity compared to the pure oil when tested against the A. aegypti larvae. Microcapsules were prepared by the process of emulsification/precipitation using the polymers of cellulose acetate (CA) and poly(ethylene-co-methyl acrylate) (PEMA), yielding four types of microcapsules: MicPEMA1 and MicPEMA2, and MicCA1 and MicCA2. When using only Copaifera sp. oleoresin, the larvicidal activity was observed at concentrations of LC50 = 48 mg/L and LC99 = 149 mg/L. For MicPEMA1, the LC50 and LC99 were 78 and 389 mg/L, respectively. Using MicPEMA2, the LC50 was 120 mg/L and LC99 >500 mg/L. For microcapsules MicCA1 and MicCA2, the LC50 and LC99 were 42, 164, 140, and 398 mg/L, respectively. For a dose of 150 mg/L of pure oleoresin, the residual activity remained above 20% for 10 days, while the dose of 400 mg/L remained above 40% for 21 days. The MicPEMA1 microcapsules showed a loss in residual activity up to the first day; however, it remained in activity above 40% for 17 days. The microcapsules of MicCA1 showed similar LC50 of pure oil with 150 mg/L.

Tài liệu tham khảo